Andrew Murphy

Biography

 Drew Murphy, PhD, joined Regeneron in 1999 as Director of Genomics and Bioinformatics. He has led the Gene Discovery and Bioinformatics group and the Target Discovery group, and is now the Senior Vice President of Regeneron Laboratories. Dr. Murphy is a co-inventor of several of Regeneron's key technologies – VelociGene® and VelocImmune® – and continues to lead several Technology Centers and Therapeutic Focus Areas. Prior to joining Regeneron, Dr. Murphy worked for seven years at Cadus Pharmaceuticals. He received his BS in Molecular Biology at the University of Wisconsin, and his PhD in Human Genetics from Columbia University, College of Physicians and Surgeons.

Research Interest

 Molecular Biology, Genomics and Bioinformatics.